ArticleApplied biochemistry and biotechnology2025
Phytochemical-Mediated Green Synthesis of Silver, Copper, and Ag-Cu Bimetallic Nanoparticles Using Peganum harmala Demonstrating Advanced Catalytic, Antioxidant, and Biomedical Applications.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Article
- Advances in metal nanoparticle-based catalysts for nitroarene reduction: from mechanistic understanding to sustainable design.RSC advances · 2026Review
- Phytochemical Profiling and Green Synthesis of Silver Nanoparticles fromMolecules (Basel, Switzerland) · 2026Article
- Sustainable green synthesis of CeORSC advances · 2026Article
- Eco-friendly Cu-TiOAMB Express · 2026Article
- Eco-friendly biosynthesis of manganese oxide-silver bimetallic nanoparticles using Cucumis melo peel extract: characterization, antioxidant, antimicrobial, and antiviral activities.Bioresources and bioprocessing · 2026Article
- Eco-friendly fabrication of Fe₃O₄/α-MnO₂ nanocomposites using Pentas schimperiana leaf extract for enhanced biomedicinal and environmental applications.Scientific reports · 2026Article
- Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.PloS one · 2026Article
- Therapeutic Metal Ions: Engineering Biomaterials for Multimodal Disease Treatment.International journal of nanomedicine · 2026Review
- Simultaneous electrochemical detection of CdRSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the green synthesis of silver (Ag-NPs), copper (Cu-NPs), and silver-copper bimetallic nanoparticles (Ag-Cu Bimetallic NPs) using the leaf extract of Peganum harmala, a sustainable and renewable plant source. This eco-friendly synthesis method avoids hazardous chemicals and minimizes waste, advancing the principles of green nanotechnology. Characterization demonstrated distinct properties; Ag-NPs, Cu-NPs, and Ag-Cu bimetallic NPs exhibited surface plasmon resonance peaks at 425 nm, 555 nm, and 525 nm, respectively, and crystallite sizes of 21.42 nm, 21.40 nm, and 26.29 nm as confirmed by X-ray diffraction. Morphological analysis revealed spherical Ag-NPs, flake-like Cu-NPs, and a mix of cubic and spherical Ag-Cu NPs. Catalytic activity tests showed Ag-Cu bimetallic NPs achieved 95% degradation of methylene blue dye, highlighting their potential in environmental remediation. Antibacterial assays demonstrated that Ag-NPs exhibited the highest inhibition zones against Bacillus subtilis (27.0 mm) and Escherichia coli (27.67 mm), while Cu-NPs were effective against Klebsiella pneumoniae at higher concentrations. Ag-NPs also exhibited significant antifungal activity, particularly against Aspergillus niger (15.00 mm). Antioxidant assays revealed Ag-Cu bimetallic NPs displayed the highest free radical scavenging capacity (59.18%), followed by Ag-NPs (35.41%). Cytotoxicity tests indicated Ag-Cu bimetallic NPs had an IC
Indexed as
Identifiers
39964595What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.